Anupama Narla
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- Cancer-related gene regulation
Papers in
- Hematology 19
- Acute Myeloid Leukemia Research 10
- Genetics 8
- Hemoglobinopathies and Related Disorders 8
- Blood disorders and treatments 4
- Co-authors
- Benjamin L. EbertSlater N. HurstMarie McConkeyNamrata D. UdeshiSteven A. CarrPeter GraumanDirk HecklStuart L. Schreiber
- Journals
- Blood (18 papers)American Journal of Hematology (5 papers)Pediatric Blood & Cancer (3 papers)Current Opinion in Hematology (2 papers)Leukemia (2 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Anupama Narla
49 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Hematology 1.1k
- Molecular Biology 3.0k
- Genetics 459
- Business and International Management 72
- Oncology 738
Countries citing papers authored by Anupama Narla
This map shows the geographic impact of Anupama Narla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anupama Narla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anupama Narla more than expected).
Fields of papers citing papers by Anupama Narla
This network shows the impact of papers produced by Anupama Narla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anupama Narla. The network helps show where Anupama Narla may publish in the future.
Co-authors
The 25 scholars most cited alongside Anupama Narla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 21 | |
| 9 | 2017 | 8 | |
| 10 | 2016 | 1 | |
| 11 | CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells Hit paper breakdown → | 2016 | 641 |
| 12 | 2015 | 15 | |
| 13 | 2015 | 98 | |
| 14 | 2014 | 55 | |
| 15 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1288 |
| 16 | 2012 | 0 | |
| 17 | 2011 | 40 | |
| 18 | 2010 | 14 | |
| 19 | 2009 | 29 | |
| 20 | 2005 | 31 |
About Anupama Narla
Anupama Narla is a scholar working on Hematology, Genetics, Molecular Biology, Physiology and Transplantation, having authored 53 papers that have together received 3.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (27 papers), Cancer-related gene regulation (14 papers), Erythrocyte Function and Pathophysiology (13 papers), Acute Myeloid Leukemia Research (10 papers), Hemoglobinopathies and Related Disorders (8 papers), Epigenetics and DNA Methylation (7 papers), Blood disorders and treatments (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Hematology (1.1k citations), Molecular Biology (3.0k citations), Genetics (459 citations), Business and International Management (72 citations) and Oncology (738 citations). Anupama Narla has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Benjamin L. Ebert, Slater N. Hurst, Marie McConkey, Namrata D. Udeshi, Steven A. Carr, Peter Grauman, Dirk Heckl, Stuart L. Schreiber, Nikhil C. Munshi and Christie Ciarlo. Their work appears in journals such as Blood, American Journal of Hematology, Pediatric Blood & Cancer, Current Opinion in Hematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.